Shares of Centene (NYSE:CNC) lost ~10% in the early premarket trading on Friday after the Medicaid-driven managed care firm ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Centene’s stock pulled a sharp U-turn into the green, after the health insurer helped assuage investor worries by providing ...

Centene stock tumbled after reporting a surprise Q2 loss, driven by rising medical costs and a weak outlook, shaking ...

Centene reported a $253 million loss in its second quarter as the provider of government-subsidized health benefits struggles ...

The California-based insurer outlined its plans to survive what CEO Joe Zubretsky deemed a “season of great uncertainty” ...

Evaluate the expected performance of Centene (CNC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for ...

Centene Corporation ( NYSE: CNC) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET a - Corporate Participant v - Corporate Participant Andrew Lynn Asher - Chief Financial Officer Jennifer ...

Centene posted adjusted earnings per share of $0.80 for the fourth quarter, exceeding the analyst consensus of $0.51 by $0.29. Revenue for the quarter came in at $40.81 billion, beating the ...

Discover Centene Corporation's Q2 2025 earnings analysis, uncovering setbacks, repricing strategies, and plans for profitability restoration.

Centene Corporation’s senior management team is set to meet investors on November 13, 2024, reaffirming their full-year adjusted earnings per share (EPS) guidance exceeding $6.80 and projecting ...